SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Expectations that Metas Muse AI agents will drive stronger CPU demand are fueling AMDs semiconductor rally and fresh highs. Bullish traders are riding the momentum, while skeptics argue the valuation has outrun fundamentals and warn of a pullback.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is drawing attention ahead of its quarterly report, as traders focus on whether AI-driven memory demand, tight DRAM supply and stronger pricing can support the outlook. Bullish expectations are balanced by concerns that the rally has raised the bar and memory remains cyclical; the Netlist patent investigation is a secondary legal-risk debate.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solars sharp selloff to a fresh 52-week low is drawing attention, with traders citing analyst target cuts and limited visibility into 2026 bookings amid uncertainty over solar trade policy and interest rates. The community is split between calling the decline an oversold buying opportunity and expecting further weakness; speculation about China-related developments remains unconfirmed.

Akamai Technologies, Inc. is the cybersecurity and cloud computing company that powers and protects business online. The market security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. The firm full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. The global enterprises trust Akamai to provide the industry reliability, scale, and expertise they need to grow their business with confidence. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

A major seven-year cloud-infrastructure agreement with Anthropic is driving attention, as traders view it as validation of Akamais AI-compute business. The community is weighing that opportunity against substantial buildout spending and potential dilution from warrants, with some celebrating the deal and others citing those costs and profit-taking as reasons for the rally to fade.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Traders are linking QNTs sharp rally to reports of Quants role in a Clearing House tokenized-deposit initiative, alongside its Robinhood listing. Bulls cite potential bank adoption and the tokens limited supply, while skeptics caution that the move may fade and question how institutional use would translate into token demand.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEARs launch of confidential perpetual futures powered by Hyperliquid, which hide traders positions by default, is widely cited as the catalyst for its sharp rally. Traders are celebrating the momentum and privacy-focused feature, while some caution the move may be an overheated pump or due for a pullback.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Attention centers on anticipation of NASAs CLPS 2.0 contract awards, which traders say have been delayed to Sept. 22 or the following week. Bulls view potential awards as a catalyst, while skeptics call the stocks volatile moves a bull trap amid weakness across space stocks.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

AEROs sharp rally is drawing attention amid anticipation of Aerodromes merger with Velodrome and expansion of its liquidity platform to Ethereum, with traders also citing Base growth and token buybacks. The community is broadly bullish on the expansion, though some remain cautious about delays and whether the price move can hold.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is centered on its Phase 3 personalized melanoma cancer-vaccine trial with Merck, which met its main endpoints, and anticipation of detailed results at the ESMO congress. Traders are celebrating the oncology potential and momentum while others argue the valuation has run ahead of unproven commercial prospects and await the full data.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

Uncertainty around U.S.-China talks and rare-earth supply is driving discussion, with traders debating whether a trade deal or easing of Chinese export restrictions could pressure MP in the near term. Others remain focused on MPs U.S. mine-to-magnet expansion and initial GM magnet deliveries as support for the longer-term domestic supply-chain thesis.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adma Biologics (ADMA) Down 4.8% Since Last Earnings Report: Can It Rebound?

Adma Biologics (ADMA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is Harmony Biosciences (HRMY) Up 12.1% Since Last Earnings Report?

Harmony Biosciences (HRMY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MYGN SHAREHOLDER ALERT: Myriad Genetics Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Myriad Genetics, Inc. (Myriad Genetics or the Company) (NASDAQ: MYGN) investors concerning the Companys and/or members of its senior managements possible violation of the federal securities laws or other...

Myriad Genetics (MYGN) Securities Investigation Notice - Levi & Korsinsky

Myriad Genetics (MYGN) Securities Investigation Notice - Levi & Korsinsky Myriad Genetics (MYGN) Securities Investigation Notice - Levi & Korsinsky PR Newswire NEW YORK, Aug. 10, 2026 Myriad Genetics reported Q2 2026 revenue of approximately $190.7 million against consensus of roughly $206-208...

MYGN Investors Have Opportunity to Join Myriad Genetics, Inc. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Myriad Genetics, Inc. (Myriad or the Company) (NASDAQ: MYGN) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses...

MYGN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Myriad Genetics (MYGN)

On May 5, 2026, Myriad Genetics (NASDAQ: MYGN) reaffirmed adjusted EBITDA of $37 million to $49 million and adjusted gross margin of 68% to 69% for full-year 2026. Roughly three months later, the adjusted EBITDA range was suspended outright and MYGN shares dropped. If you held Myriad Genetics stock...

MYGN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Myriad Genetics

MYGN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Myriad Genetics MYGN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Myriad Genetics PR Newswire NEW YORK, Aug. 4, 2026 Myriad Genetics guided to...

Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN)

Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN) Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN) PR Newswire NEW YORK, Aug. 3, 2026 On May 5...

Why Did RBLX, HTZ, MYGN Stocks Plunge To 52-Week Lows Last Week?

Equity

Investors became less willing to wait for companies’ long-term plans when those businesses continued to face problems delivering results in the short term. 


Myriad Genetics Stock Drops Sharply After Hours: What Investors Need to Know

Myriad Genetics stock fell after hours after weak Q2 results, lower guidance and an operating loss.read more...

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Current Price	$4.14
Prev Close	$4.01
Open	$4.00
Dividend Yield	0.00%
50-Day Moving Average	$3.86
Beta	1.14
Avg. Volume	2.08M
PE Ratio	-3.45

52-Week High	$8.59
52-Week Low	$2.74
Market Capitalization	$383.56M
EPS (Annual)	-$3.95
Price to Book	1.30
Revenue Per Employee	$305,370.37

Feed

News

Sentiment

Earnings

Fundamentals

Info

MYGN Fundamentals